CBPD-268
Product Specifications
Target
PROTACs, Histone Acetyltransferase
Related Pathways
Chromatin/Epigenetic, PROTAC
Bioactivity
CBPD-268 is an effective orally active CBP/p300 PROTAC degrader, with a DC50 value of ≤ 0.03 nM. It induces degradation of CBP/p300 and inhibits cell growth, exhibiting antitumor activity. Additionally, CBPD-268 shows potential for research in AR-positive prostate cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K5017202 1.0 µg DNA
Zfp113 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
